Sponsored Links
| Trius Therapeutics To Conform Protocol For Upcoming Torezolid Phosphate Phase 3 Trial With Newly Released FDA Draft Guidance |
 |
 |
 |
| Pharmacy - Pharma Industry - Biotech Industry | |||
|
Trius Therapeutics, Inc. announced that on February 26th, 2010, the FDA issued new draft guidance on non-inferiority clinical trials that will apply to the design of the Company's proposed Phase 3 trials for its investigational antibacterial drug torezolid phosphate... Read more: Pharma Industry / Biotech Industry News From Medical News Today
|